LEADER 01586nam  2200373   450 
001 9910819339003321
005 20230814233023.0
010   $a3-7369-8768-4
035   $a(CKB)4100000008332714
035   $a(MiAaPQ)EBC5407560
035   $a(EXLCZ)994100000008332714
100   $a20190716d2018      uy|            0
101 0 $aeng
135   $aurcnu||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aMechanistic understanding of enhanced human oral bioavailability of fenofibric acid from novel lipid carriers using semi- physiologically based pharmacokinetic model and various analytical approaches including biorelevant dissolution testing /$fby Yang Fei from Hohhot, China
205   $a1. Auflage.
210  1$aFrankfurt am Main :$cCuvillier,$d2018.
215   $a1 online resource (223 pages) $cillustrations
300   $a"Submitted to faculty 14 Biochemistry, Chemistry and Pharmacy of the Johann Wolfgang Goethe University in Frankfurt am Main."
311   $a3-7369-9768-X 
320   $aIncludes bibliographical references.
606   $aBioavailability
615  0$aBioavailability.
700   $aFei$b Yang$01618918
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910819339003321
996   $aMechanistic understanding of enhanced human oral bioavailability of fenofibric acid from novel lipid carriers using semi- physiologically based pharmacokinetic model and various analytical approaches including biorelevant dissolution testing$93950917
997   $aUNINA